1 Magnificent Dividend Growth Stock That Could Soar 20% in 2025, According to a Couple of Wall Street Analysts
On Monday, Jan. 7, Michael Lavery at Piper Sandler initiated coverage of the beverage giant, with an overweight rating and a ...
TD Cowen Keeps Their Buy Rating on Rhythm Pharmaceuticals (RYTM)
TD Cowen analyst Phil Nadeau maintained a Buy rating on Rhythm Pharmaceuticals (RYTM – Research Report) today. The company’s shares opened ...
TD Cowen's investment themes for 2025: Spotting opportunities and risks
Lisa Thomas, Managing Director and Deputy Head of Global Research at TD Cowen, discusses some of the key findings of a new TD Cowen report on the big investment themes of 2025, including shifting ...
Thomas: The word of the day is choppy.
Lisa Thomas, Managing Director and Deputy Head of Global Research at TD Cowen, describes the current market as "choppy," indicating the need for careful navigation. She emphasizes the importance of ...